SUPN
#1851
Supernus Pharmaceuticals, Inc. - Common Stock
43.7 6 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.97%
Variación mensual
-7.72%
Variación en los últimos 6 meses
-18.95%
Cambio anual
-18.96%
Cierres anteriores
44.1 9
Open
43.6 3
Mínimo
43.3 7
Máximo
43.7 6
Volumen
401
Financials
- Market Capitalization 2.54 B
- Employee 778
- Founded 2005
- CEO Jack A. Khattar
- Website www.supernus.com
- Headquarter Delaware, United States
- FIGI BBG000BP0HX7
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-73.09
Relación precio/flujo de caja
3.9
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1498 |  INDV Indivior Pharmaceuticals, Inc. - Common Stock | 34.86 USD | -1.25% | -5.45% | -15.55% | +3.75% | 4.11 B USD | ||
| 1788 |  RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.50 USD | -0.36% | +3.77% | -7.87% | -63.04% | 2.72 B USD | ||
| 1862 |  PBH Prestige Consumer Healthcare Inc. Common Stock | 52.41 USD | +2.38% | +2.50% | +1.79% | -22.33% | 2.48 B USD | ||
| 1889 |  BHC Bausch Health Companies Inc. Common Stock | 6.32 USD | +0.32% | -1.56% | +37.99% | -11.36% | 2.36 B USD |